Chr. Hansen Holding A/S (CHYHY) Stock Price, News & Analysis

Company Overview

Chr. Hansen Holding A/S was a Danish bioscience company that developed and produced natural ingredient solutions for the food, health and agricultural industries. Its portfolio included microbial cultures, enzymes, probiotics, natural colors and related products used to support food fermentation, preservation, flavor, animal health and plant health.

The company supplied ingredients and biological solutions to customers worldwide, serving markets such as dairy, meat, beverages, dietary supplements, pharmaceuticals, animal feed and agriculture. Its products were used by food manufacturers and other industrial customers to improve product quality, functionality, shelf life and sustainability.

Chr. Hansen traced its origins to 1874, when Danish pharmacist Christian D.A. Hansen began producing microbial cultures for cheesemaking. The company operated internationally for many years, with research, production and commercial activities across Europe, North America, Asia and other global markets.

In 2023, Chr. Hansen combined with Novozymes to form Novonesis, a global biosolutions company. As a result, Chr. Hansen no longer operates as a standalone business under its former corporate structure. Mauricio Graber served as Chr. Hansen’s chief executive officer before the combination.

Key Stats

• Today's Range: $19.42 to $19.86
• 50-Day Range: $19.59 to $19.59
• 52-Week Range: $14.73 to $25.32
• Volume: 7,300 shs
• Average Volume: 13,855 shs
• Market Capitalization: N/A
• P/E Ratio: 38.78
• Dividend Yield: 0.83%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: OTCMKTS:CHYHY
• CIK: N/A
• Web: www.chr-hansen.com
• Phone: (454) 574-7474
• Fax: N/A
• Employees: 3,834
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 38.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A